1.Core Information

　　The Department of Gastrointestinal Surgery at the Third People's Hospital of Shenzhen is a regional diagnosis and treatment center integrating medical care, teaching, and research. As a core surgical department of the National Clinical Research Center for Infectious Diseases, it undertakes comprehensive surgical treatment for complex and specific infections in the Pearl River Delta. The department has a team of 32 professionals, including 5 Consultants/Associate Consultants, 8 Attending/Resident Physicians, and 19 specialized nurses (including 1 International Enterostomal Therapist).

　　2.Clinical Services

• Gastrointestinal Malignancies

　　Gastric, colorectal cancer, and GIST: Radical resection of gastrointestinal cancer using the da Vinci Surgical System and 4K ultra-HD laparoscopy.

　　Advanced gastrointestinal tumors: Multidisciplinary team (MDT) comprehensive treatment applying Hyperthermic Intraperitoneal Chemotherapy (HIPEC) combined with targeted and immunotherapy.

• Hernia and Abdominal Wall Diseases
  

　　Inguinal, incisional, and hiatal hernias: Laparoscopic repair of various complex hernias (e.g., TAPP, TEP). The department is a registered unit of the Chinese Hernia Registry.

• Obesity and Metabolic Syndrome

　　Severe obesity and metabolic diseases: Minimally invasive bariatric and metabolic surgery, including Laparoscopic Sleeve Gastrectomy (LSG) and Roux-en-Y Gastric Bypass (RYGB).

• Complex Anorectal and Infectious Surgical Diseases
  

　　Complex anal fistula and severe hemorrhoids: Procedure for Prolapse and Hemorrhoids (PPH) and Tissue-selecting Therapy (TST).

Specific infections with surgical conditions: Minimally invasive surgical treatment for patients with special infections such as HIV and tuberculosis.

　　3.Special Features & Advantages

　　The department has significant advantages in minimally invasive surgery, routinely performing da Vinci robotic and laparoscopic surgeries, with minimally invasive procedures accounting for over 90% of all operations. It has accumulated extensive experience in single-port, reduced-port laparoscopy, and Natural Orifice Specimen Extraction Surgery (NOSES), achieving a combination of "minimally invasive and scarless" outcomes for gastrointestinal tumor surgeries. Core technologies such as total laparoscopic digestive tract reconstruction and laparoscopic incisional hernia repair have reached an internationally advanced level.

　　Relying on the platform of the National Clinical Research Center for Infectious Diseases, the department is the only specialty in the Pearl River Delta capable of comprehensively treating surgical diseases complicated by specific infections (such as HIV and tuberculosis). Under strict nosocomial infection control standards, the team has successfully performed high-quality surgeries for a large number of patients with special infections, featuring a low complication rate and high patient satisfaction, establishing its leading position as a regional infection surgery treatment center.

　　The department fully implements the Enhanced Recovery After Surgery (ERAS) concept. Through multidisciplinary collaboration among surgery, anesthesia, nursing, and nutrition teams, the postoperative recovery cycle of patients is significantly shortened. Led by an International Enterostomal Therapist, the specialized nursing team possesses outstanding professional advantages in the whole-process integrated management of enterostomies, moist healing treatment of complex wounds, standardized enteral nutrition support, and intravenous access management (such as PICC and implantable ports).

　　4.Education & Research

　　As a crucial part of a regional medical center and high-level teaching hospital, the department undertakes clinical teaching and master's degree training tasks for multiple medical universities. It is also a core rotation department for the National Standardized Residency Training Base (Surgery). The department actively engages in domestic and international academic exchanges, regularly hosting seminars on minimally invasive gastrointestinal surgery and new advances in infection surgery to continuously enhance the discipline's international perspective.

　　Supported by the National Clinical Research Center for Infectious Diseases, the department focuses on clinical and basic research in the minimally invasive treatment of gastrointestinal tumors and specific infection surgery. Over the past five years (2021-2026), the team has undertaken and participated in multiple national, provincial, and municipal research projects; published over 20 high-impact SCI papers in core journals; obtained several national utility model and invention patents; and received provincial and municipal medical science and technology awards for various clinical research outcomes, effectively translating research achievements into clinical practice guidelines that directly benefit patients.